Questionnaire Based Assessment of Patients’ Acceptability of Leukocytapheresis for the Treatment of Inflammatory Bowel Disease.

Kazuko Nagase ¹, Ken Fukuanga, Yoko Yokoyama, Koji Kamikozuru, Hiroto Miwa, Shiro Nakamura, Ther Apher Dial. 2013 Oct;17(5):490-7.

The aim of the present study was to assess patients’ acceptance of therapeutic leukocytapheresis known as cytapheresis (CAP) for the treatment of an active flare of inflammatory bowel disease (IBD).

https://pubmed.ncbi.nlm.nih.gov/24107277/